help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sowers, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sowers, J. R.

Journal of Clinical Endocrinology & Metabolism, Vol 53, 1133-1137, Copyright © 1981 by Endocrine Society

ARTICLES

Dopaminergic control of circadian norepinephrine levels in patients with essential hypertension

JR Sowers

This study examines the influence of dopamine on recumbent circadian mean arterial blood pressure (MAP) levels and secretory patterns of norepinephrine (NE) in essential hypertension. Nine patients with sustained essential hypertension were studied after they had reached metabolic equilibrium of a constant 100-mmol sodium and 80-mmol potassium intake. MAP measurements and plasma NE determinations were made at 30-min intervals over 24 h during a control (no medication) and a bromocriptine (BEC) period (2.5 mg, three times a day for 5 days). In the control period, a clear circadian rhythm in blood pressure was evidenced in these hypertensive patients, with lowest MAP occurring during sleep. NE was secreted in an episodic manner, with most secretory peaks occurring between 0600-1800 h. Sleep was characterized by lower levels of NE than in waking hours and a paucity of secretory peaks. During the control period, recumbent 24-h MAP was strikingly correlated with plasma NE (gamma = 0.67; P less than 0.001). BEC treatment was associated with a depression in MAP throughout the 24-h cycle and a lessening of the relationship between MAP and plasma NE (gamma = 0.35; P less than 0.025). BEC eliminated much of the circadian variation in plasma NE secretion in these hypertensives. Thus, circadian variations in sympathetic nervous system activity and blood pressure in patients with essential hypertension appear to be modulated by a central and/or peripheral dopaminergic mechanism.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
P. Kok, F. Roelfsema, M. Frolich, J. van Pelt, A. E. Meinders, and H. Pijl
Activation of Dopamine D2 Receptors Lowers Circadian Leptin Concentrations in Obese Women
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3236 - 3240.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
H. P. Schobel, R. E. Schmieder, S. Hartmann, H. Schachinger, and F. C. Luft
Effects of Bromocriptine on Cardiovascular Regulation in Healthy Humans
Hypertension, May 1, 1995; 25(5): 1075 - 1082.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1981 by The Endocrine Society